Design Therapeautics Share Price (NASDAQ: DSGN)
$5.44
Live
Last updated on
Check the interactive Design Therapeautics Stock chart to analyse performance
Design Therapeautics stock performance
as on August 30, 2025 at 12:38 am IST
- Today's Low:$5.32Today's High:$5.46
2.21%
Downside
Day's Volatility :2.56%
Upside
0.37%
- 52 Weeks Low:$2.6052 Weeks High:$7.77
52.21%
Downside
52 Weeks Volatility :66.54%
Upside
29.99%
Design Therapeautics Stock Returns
Design Therapeautics, Inc. Key Stats
Check Design Therapeautics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Design Therapeautics Stock including INR - Dollar returns
The Design Therapeautics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Design Therapeautics investment value today
Current value as on today
₹1,20,818
Returns
₹20,818
(+20.82%)
Returns from Design Therapeautics Stock
₹15,499 (+15.5%)
Dollar Returns*
₹5,319 (+5.32%)
Indian investors sentiment towards Design Therapeautics Stock
Global Institutional Holdings in Design Therapeautics, Inc.
Name
Holdings %
SR ONE CAPITAL MANAGEMENT, LP
11.46%
Logos Global Management LP
7.41%
BlackRock Inc
4.35%
Point72 Asset Management, L.P.
3.17%
TANG CAPITAL MANAGEMENT LLC
3.13%
Baker Bros Advisors LP
3.01%
Analyst Recommendation on Design Therapeautics Stock
Hold
0%Buy
62%Hold
37%Sell
Based on 8 Wall street analysts offering stock ratings for Design Therapeautics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Design Therapeautics Share Price Target
What analysts predicted
Upside of 34.8%
Target:
$7.33
Current:
$5.44
Design Therapeautics share price target is $7.33, a slight Upside of 34.8% compared to current price of $5.44 as per analysts' prediction.
Design Therapeautics Stock Insights
Price Movement
In the last 7 days, DSGN stock has moved up by 7.4%DSGN vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 57.5% return, outperforming this stock by 37.5%DSGN vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.3% return, outperforming this stock by 188.5%Price to Sales
ForDSGN every $1 of sales, investors are willing to pay $5650.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.8 for every $1 of sales.
Design Therapeautics Technicals Summary
Sell
Neutral
Buy
Design Therapeautics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Design Therapeautics, Inc. Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 40.2% | 16.26% | 19.96% | -71.16% | -86.38% |
 | 3.77% | -17.64% | -51.18% | -2.19% | -7.17% |
 | -0.02% | 10.33% | 51.07% | 81.16% | 24.14% |
 | -16.39% | -18.24% | -20.49% | 39.42% | 40.54% |
 | 33.05% | 83.22% | 57.52% | 115.32% | 240.85% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -1.34 | -0.27 | -0.19 | NA | 3.74 |
| 14.79 | 14.79 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.69 | 27.69 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Hold | $301.3M | -86.38% | NA | 0.0% |
| Buy | $62.2B | -7.17% | 14.79 | 31.37% |
| NA | $36.8B | 24.14% | NA | -3.89% |
| Buy | $99.8B | 40.54% | 27.69 | 31.86% |
| Buy | $59.1B | 240.85% | NA | -12.96% |
About Design Therapeautics, Inc.
Key Management of Design Therapeautics, Inc.
Important FAQs about investing in DSGN Stock from India :
What is Design Therapeautics share price today?
Design Therapeautics share price today is $5.44 as on . Design Therapeautics share today touched a day high of $5.46 and a low of $5.32.
What is the 52 week high and 52 week low for Design Therapeautics share?
Design Therapeautics share touched a 52 week high of $7.77 and a 52 week low of $2.60. Design Therapeautics stock price today i.e. is trending at $5.44, lower by 29.99% versus the 52 week high.
How to invest in Design Therapeautics Stock (DSGN) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Design Therapeautics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Design Therapeautics Shares that will get you 0.2757 shares as per Design Therapeautics share price of $5.44 per share as on August 30, 2025 at 12:38 am IST.
What is the minimum amount required to buy Design Therapeautics Stock (DSGN) from India?
Indian investors can start investing in Design Therapeautics (DSGN) shares with as little as ₹88.286 or $1 (as of August 29, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Design Therapeautics stock (as per the Rupee-Dollar exchange rate as on August 29, 2025).
Based on Design Therapeautics share’s latest price of $5.44 as on August 30, 2025 at 12:38 am IST, you will get 1.8382 shares of Design Therapeautics. Learn more about
fractional shares .
What are the returns that Design Therapeautics has given to Indian investors in the last 5 years?
Design Therapeautics stock has given -86.38% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
Enhabit Inc$7.86
-0.76%
Lantern Pharma Inc$4.06
+0.0%
Ars Pharmaceuticals Inc$11.76
-8.55%
Orthofix Medical Inc$14.90
+1.09%
Gossamer Bio Inc$2.46
+2.5%
Prelude Therapeutics Inc$1.27
-3.05%
Xeris Biopharma Holdings Inc$7.72
-2.28%
Curis Inc$1.70
+1.8%
Airsculpt Technologies$6.48
-2.7%